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OBJECTIVE—Recent evidence indicates that low oxygen ten-
sion (pO2) or hypoxia controls the differentiation of several cell
types during development. Variations of pO2 are mediated
through the hypoxia-inducible factor (HIF), a crucial mediator of
the adaptative response of cells to hypoxia. The aim of this study
was to investigate the role of pO2 in -cell differentiation.
RESEARCH DESIGN AND METHODS—We analyzed the ca-
pacity of -cell differentiation in the rat embryonic pancreas
using two in vitro assays. Pancreata were cultured either in
collagen or on a ﬁlter at the air/liquid interface with various pO2.
An inhibitor of the prolyl hydroxylases, dimethyloxaloylglycine
(DMOG), was used to stabilize HIF1 protein in normoxia.
RESULTS—When cultured in collagen, embryonic pancreatic
cells were hypoxic and expressed HIF1 and rare -cells differ-
entiated. In pancreata cultured on ﬁlter (normoxia), HIF1
expression decreased and numerous -cells developed. During
pancreas development, HIF1 levels were elevated at early
stages and decreased with time. To determine the effect of pO2
on -cell differentiation, pancreata were cultured in collagen at
increasing concentrations of O2. Such conditions repressed
HIF1 expression, fostered development of Ngn3-positive endo-
crine progenitors, and induced -cell differentiation by O2 in a
dose-dependent manner. By contrast, forced expression of
HIF1 in normoxia using DMOG repressed Ngn3 expression and
blocked -cell development. Finally, hypoxia requires hairy
and enhancer of split (HES)1 expression to repress -cell
differentiation.
CONCLUSIONS—These data demonstrate that -cell differen-
tiation is controlled by pO2 through HIF1. Modifying pO2 should
now be tested in protocols aiming to differentiate -cells from
embryonic stem cells. Diabetes 59:662–669, 2010
A
t low oxygen tension (pO2), cells undergo ad-
aptative changes, including increased angio-
genesis and erythropoiesis, and a switch to
glycolytic metabolism (1). The cellular re-
sponse to hypoxia is tightly controlled by the hypoxia-
inducible factor (HIF) complex, an (/) heterodimer (2).
HIF is regulated in an O2-dependent manner by hydroxy-
lation of one of the three HIF subunits (HIF1, HIF2,
and HIF3) (3,4). HIF1 was the original HIF isoform
identiﬁed by afﬁnity puriﬁcation using oligonucleotides
from the erythropoitin (EPO) locus, whereas HIF2 and
HIF3 were identiﬁed by homology searches. These -sub-
units are expressed differentely and independently in
different time frames (5–7). In normoxia, hydroxylation of
the proline HIF1 residues by prolyl hydroxylases leads to
recognition and polyubiquitinylation by the Von Hippel-
Lindau (VHL) E3 ligase complex, leading to proteasomal
degradation of HIF1 (8,9). On the other hand, in the
hypoxic state, prolyl hydroxylase activity is decreased and
HIF1 is stabilized. During embryogenesis, cell oxygen-
ation levels vary widely. In general, pO2 is considered to
occur at 2–9% O2 decreasing to even lower levels in tissues
such as kidney medulla, bone marrow, or thymus (10).
Recent investigations of the role of hypoxia and HIF1
during development of several organs showed that hyp-
oxia decreases the differentiation of neural precursor
cells, myogenic cells, adipocytes, and endothelial cells in
an HIF1-dependent manner (11–13).
The pancreas originates from the dorsal and ventral
regions of the foregut endoderm directly behind the stom-
ach. Signals derived from adjacent mesodermal structures,
notochord, dorsal aorta, and cardiac mesoderm induce
initiation of pancreas development (14–17). Next, mesen-
chyme condenses around the underlying committed
endoderm; mesenchyme is also involved in the control of
pancreas development (18). Embryonic pancreatic epithe-
lium contains progenitor cells that express the transcrip-
tion factor pancreatic and duodenal homeobox factor one
(PDX1), whose deletion leads to pancreatic agenesis (19).
Other transcription factors are also important for pancre-
atic development (20). Interestingly, the transcription fac-
tor Ngn3 is transitorily expressed in pancreatic endocrine
progenitor cells during development, and its deletion leads
to the absence of the four endocrine cell types (, , , and
PP) that produce glucagon, insulin, somatostatin, and
pancreatic polypeptide, respectively (21).
Advances in the understanding of signals that control
pancreatic development have been made using in vivo and
in vitro reconstituted models (15,22–24). In the present
study, we found that when rat embryonic pancreata were
cultured in collagen gels, cells were hypoxic, HIF1 was
stabilized, Ngn3 expression was not induced, and conse-
quently, -cell differentiation was arrested. However, in-
creasing pO2 led to HIF1 degradation, upregulation of
Ngn3 expression, and -cell differentiation. Similarly,
when pancreata were cultured on ﬁlter at the air-medium
interface, where tissues are not subject to hypoxia, HIF1
was not expressed, Ngn3 was induced, and -cells devel-
oped. Under such conditions, reduction of pO2 stabilized
HIF1 levels and decreased both Ngn3 expression and
-cell development. Moreover, HIF1 stabilization using
prolyl-hydroxylase inhibitors repressed -cell develop-
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tion factor involved in pancreas development (25), was
induced both by hypoxia and by forced expression of
HIF1 in normoxia. Moreover, inhibition of the Hes1
expression by a -secretase inhibitor in hypoxic condi-
tions restored normal development of Ngn3-expressing
progenitor cells. Finally, we found that HIF1 is tempo-
rally regulated during pancreas development in vivo.
Based on these ﬁndings, we hypothesized that differences
in pO2 were responsible for such changes in -cell devel-
opment. Thus, we propose that pO2 is a regulator of
pancreatic endocrine cell development, acting through
HIF1.
RESEARCH DESIGN AND METHODS
Pregnant Wistar rats were purchased from the Janvier breeding center
(CERJ). The animals had free access to food pellets and water. The ﬁrst day
postcoitus was taken as embryonic day 0.5 (E0.5). At 13.5 days’ gestation,
pregnant female rats were killed by asphyxiation with carbon dioxide or by a
lethal injection of ketamin/xylazin according to the guidelines of the French
Animal Care Committee.
Hypoxia in vivo. Pregant Wistar rats at 13.5 days postcoitus were subjected
to hypoxia in the anaerobic workstation at 25°C and in a humidiﬁed atmo-
sphere (95%) supplied with the gas mixture allowing it to adjust the hypoxic
environment by gradually decreasing the O2 level from 21 to 8 and 92% N2. The
rats were provided with food and water ad libitum. The animal study protocols
were conducted according to institutional guidelines for animal use.
Dissection of pancreatic rudiments and organ culture. Embryos were
harvested at E13.5. The dorsal pancreatic bud was dissected as described
previously (23). For cultures at the air-medium interface, the dorsal pancreatic
rudiments were laid on Millicell culture plate inserts (Millipore) (24). DMOG
(Interchim) was used at concentrations of 1 and 2 mmol/l, and the -secretase
inhibitor XXI (Calbiochem) was used at a concentration of 250 nmol/l.
L-mimosine (Sigma) was used at a concentration of 400 mol/l. For collagen
cultures, pancreatic explants were embedded in 500-l collagen gels as
previously described (23). All cultures were maintained at 37°C in humidiﬁed
5% CO2 in a hypoxia chamber at various levels of pO2.
Detection of hypoxia. To detect hypoxic areas, the dorsal pancreatic
rudiments were cultured for either 24 h or 7 days in collagen and at the
air-medium interface. Pimonidazole (200 mol/l; Hypoxyprobe, NPI) was
added to culture medium during the last2ho ft h eculture period. Pancreatic
explants were analyzed with an anti-Mab1 ﬂuorescent antibody (NPI) accord-
ing to the manufacturer’s instructions.
Immunohistochemistry. Tissues were ﬁxed in 10% formalin and processed
for immunohistochemistry as previously described (23,26). The following
antibodies were used: mouse anti-insulin (1:2,000; Sigma-Aldrich), rabbit
anti-PDX1 (1:1,000) (26), rabbit anti-carboxypeptidase A (1:600; Biogenesis),
mouse anti–E-cadherin (1:100; BD Biosciences), rabbit anti-HES1 (1:1,000 [a
gift from Dr. Tetsuo Sudo, Pharmaceutical Research Laboratories, Toray
Industries, Tebiro, Kamakura, Japan]), mouse anti-BrdU (1:2; Amersham),
rabbit anti-NGN3 (1:1,000) (27), and rabbit anti-HIF1 (9). The ﬂuorescent
secondary antibodies were ﬂuorescein-isothiocyanate anti-rabbit and Texas
Red anti-mouse antibodies (1:200; Jackson Immunoresearch) and Alexa-ﬂuor
anti-rabbit antibody (1:400; Biogenex). For NGN3, revelation was performed
using the vectastain ABC kit (Vector). For HIF1, revelation was performed
with an anti-rabbit Dakocytomation Envision system HRP-DAB (Dako).
Photographs were taken using a ﬂuorescence microscope (Leica, Leitz
DMRB) and digitized using a Hamamatsu C5810 cooled 3CCD camera. No
signals were observed when the primary antibodies were omitted.
Transferase-mediated dUTP nick-end labeling experiments. The transferase-
mediated dUTP nick-end labeling (TUNEL) procedure was performed using
an in situ cell death detection kit (Roche) according to the manufacturer’s
instructions. Subsequently, E-cadherin (1:100; BD Biosciences) immuno-
staining was used to visualize the epithelium.
Quantiﬁcation. To quantify the absolute numbers of insulin-expressing cells,
all sections of each pancreatic rudiment were digitized. On every image, the
surface area of insulin staining was quantiﬁed using IPLab Eval (version 3.2.4;
Scanalytics), and the stained areas were tallied as previously described (24).
Three to ﬁve rudiments were analyzed per condition.
To measure proliferation of early progenitors expressing PDX1, we
counted the frequency of BrdU
 nuclei among 1,000 PDX1
 cells. The
percentage of undifferentiated PDX1-expressing cells was then calculated.
Three rudiments were analyzed per condition. Statistical signiﬁcance was
determined using Student’s t test.
In situ hybridization. Tissues were ﬁxed at 4°C in 4% paraformaldehyde,
cryoprotected in 15% sucrose at 4°C overnight, embedded in 15% sucrose and
7.5% gelatin, and frozen in isopentane. Cryosections (14 m thick) were
prepared. An Ngn3 probe (726 bp) was used and in situ hybridization
performed as previously described (24). No signal was obtained using a sense
riboprobe.
Real-time PCR. Total RNA was puriﬁed using the Rneasy microkit (Qiagen).
The cDNA was generated using Superscript reagents (Invitrogen), and the
real-time PCR was performed on a 7300 real-time PCR system (Applied
Biosystem) with an SYBR Green PCR master mix. The oligonucleotide
sequences for RT-PCR are available on request.
Western blotting. For Western blot analysis, cells were lysed in Laemmli
buffer. Proteins (20 g) were resolved by SDS/PAGE and electrophoretically
transferred onto a polyvinylidine ﬂuoride membrane (Biorad). After blocking
with milk, membranes were probed with rabbit anti-HIF1 or anti-HIF2
antibodies (Novus) and mouse anti-actin (Sigma-Aldrich). Immunoreactive
bands were visualized with the SuperSignal system (Pierce).
RESULTS
Pancreatic -cell differentiation depends on cell ox-
ygenation. We cultured E13.5 rat pancreata in collagen.
While acinar cells expressing carboxypeptidase-A devel-
oped, NGN3 expression was poorly induced and -cells
did not develop. However, when we cultured them on a
ﬁlter at the air-medium interface, NGN3 expression was
induced and insulin-positive cells developed (Fig. 1A).
When pimonidazole staining was applied, we found that
collagen-cultured tissues were hypoxic from day 1 to day
7, which was not the case for pancreata cultured at the
air-medium interface (Fig. 1B).
To investigate the role of O2 in -cell differentiation, we
cultured pancreatic explants in collagen with increased
pO2. When pancreata were cultured at 21% O2, very few
-cells were detected on day 7 (Fig. 2A). At 60 and 80% O2,
the surface of insulin staining increased 25.1- and 81.2-
fold, respectively, compared with cultures at 21% O2 (Fig.
2A). Next, we examined development of different types of
endocrine cells (, , and  cells) using quantitative
real-time PCR (qPCR). When pancreatic buds were cul-
tured at 80% O2, glucagon-, insulin-, and somatostatin-
mRNA steady-state levels were increased 8.3-, 175.1-, and
8.9-fold, respectively, compared with levels induced at 21%
O2 (supplementary Fig. S1, which can be found in an
online appendix at http://diabetes.diabetesjournals.org/
cgi/content/full/db09-0891/DC1). Thus, pancreatic endo-
crine cell development is controlled by pO2. Interestingly,
oxygen tension had no effect on acinar cell development
(Fig. 2A).
To determine whether the increased -cell development
was due to higher cell survival or increased differentiation,
we compared the rates of cell apoptosis at day 1 in
pancreata cultured at 21 and 80% O2. Results of TUNEL
staining detected very few apoptotic cells in the epithelia
of pancreata treated in either culture (Fig. 2B). Some
apoptotic cells were found in the mesenchyme; however,
the numbers of apoptotic cells were similar for tissues in
both cultures. Next, we used qPCR to compare Ngn3
expression in pancreata cultured at 21 and 80% O2 for 1, 3,
and 5 days. At all time points, increased pO2 induced Ngn3
expression (Fig. 2C). Immunohistochemistry analysis con-
ﬁrmed these results (supplementary Fig. S2). Altogether,
these data indicate that increased oxygen tension activates
-cell differentiation as opposed to enhancing cell survival.
HIF1 signaling pathway is induced by hypoxia in the
pancreas. In various cell types, hypoxia stabilizes HIF1
and activates the HIF transcription complex. In our study,
we used Western blot analysis to determine whether
HIF1 was stabilized in pancreata cultured in collagen.
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increased dramatically compared with those cultured at
80% O2 (Fig. 3A). To conﬁrm these results, we used
immunohistochemistry. Both HIF1 and pimonidazole
were detected at low but not high oxygen tension (Fig.
3B). We also analyzed the expression of HIF1 targets.
Using qPCR, we found that expression of the glycolytic
enzymes Pgk1 and LdhA, as well as expression of Glut1,
Vegf, and Redd1, increased 9.1-, 8.4-, 11.3-, 4.1-, 4.7-fold,
respectively, when cultured at 21% O2 compared with 80%
O2 (Fig. 3C). Taken together, these results demonstrate
that the HIF1 signaling pathway is active in collagen
culture at 21% O2, but not at 80% O2.
Stabilization of HIF1 at normoxia mimicks the ef-
fects of hypoxia on -cell differentiation. To deter-
mine whether HIF1 was responsible for the arrest of
-cell differentiation under hypoxic conditions, we devel-
oped an approach to stabilize HIF1 under normoxic
conditions. To this end, we ﬁrst showed that when pan-
creata were cultured on a ﬁlter at the air-medium inter-
face, low pO2 induced HIF1 but not HIF2 accumulation
(Fig. 4A and supplementary Fig. S3) and increased tran-
scription of the HIF1 target genes Pgk1, LdhA, Glut1,
Vegf, and Redd1 (supplementary Fig. S4). HIF1 was
expressed in the pimonidazole-positive areas (supplemen-
tary Fig. S5A), as was the case when pancreata were
cultured in collagen (Fig. 3B). Moreover, under hypoxic
conditions, Ngn3 expression decreased both in mRNA
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FIG. 1. Differential development of -cells between pancreata cultured
in collagen and at the air-medium interface. A: E13.5 pancreata were
cultured in collagen or on a ﬁlter at the air-medium interface for 3 or
7 days. At day 3, NGN3 was detected by immunohistochemistry (in
brown). At day 7, anti-insulin (INS) (in red) and anti-carboxypepti-
dase A (CPA) (in green) antibodies were used to detect - and acinar
cell development, respectively. B: Hypoxia was analyzed in pancreata
cultured in collagen and at the air-medium interface. After 1 or 7 days,
pimonidazole was added to the medium for the last2ho ft h eculture
period and hypoxia was analyzed using anti-Mab1 antibodies (in
green). Bar: 50 m. (A high-quality digital representation of this ﬁgure
is available in the online issue.)
A
R
e
l
a
t
i
v
e
 
N
g
n
3
 
m
R
N
A
Cumulated surface of Insulin staining
per rudiments (mm2)
Days in culture
B
C
2
1
%
 
O
2
6
0
 
%
 
O
2
8
0
 
%
 
O
2
21 % O2 80 % O2
*
*
INS / CPA
TUNEL
E-Cadh
100
50
0
0135
**
*
**
0 0.5 1 1.5
FIG. 2. Induction of -cell differentiation by increasing pO2 in collagen.
A: Pancreata were cultured for 7 days at 21, 60, and 80% O2. - and
acinar cells were detected by immunohistochemistry with antibodies
directed against insulin (INS) (in red) and carboxypeptidase A (CPA)
(in green). Next, the absolute surface area occupied by insulin-positive
cells was quantiﬁed. B: Apoptotic cells (in green) were detected using
a TUNEL reaction assay in pancreata cultured for 1 day at 21 or 80%
O2. The epithelial cells were detected using an anti–E-cadherin anti-
body (in red). Note the absence of apoptotic cells within the epithe-
lium. C: Real-time PCR quantiﬁcation of Ngn3 mRNA in pancreata
cultured at 21% ( ) or 80% (f)O 2 at different time points. Gene
expression is presented as a percentage of the highest sample. Each
point represents the mean  SEM of three individual data pools. *P <
0.05; **P < 0.01. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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mass dramatically decreased (Fig. 4C). To evaluate the
impact of oxygen tension on the proliferation of the
precursor cells, we measured BrdU incorporation in pan-
creata cultured with 21 or 3% O2 for 1 day (supplementary
Fig. S6). There was a twofold decrease of BrdU incorpo-
ration in Pdx1-positive progenitors in the explants in
hypoxia compared with normoxia. Thus, oxygen tension
controls the proliferation of the progenitor cells. This
effect should participate in the control of the number of
NGN3-positive cells and the ﬁnal -cell mass. Next, we
stabilized HIF1 at normoxia with dimethyloxaloylglycine
(DMOG), a competitive inhibitor of prolyl hydroxylases
(28). As shown in Fig. 4D, DMOG treatment caused HIF1
accumulation and induction of the HIF1 target genes in a
dose-dependent manner (supplementary Fig. S7). On the
contrary, DMOG did not stabilize HIF2 (supplementary
Fig. S3). Interestingly, under normoxic conditions, DMOG
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FIG. 3. The HIF1 signaling pathway is induced by hypoxia in the
pancreas. A: Protein extracts from pancreata cultured in collagen for 1
day at 21 or 80% O2 were analyzed by Western blot to quantify HIF1
expression and -actin (loading control). B: Pancreata were cultured
for 1 day at 21 or 80% O2 and pimonidazole was added in the culture
medium during the last2ho ft h eculture. HIF1-positive cells were
detected by immunohistochemistry (in brown). On serial sections,
hypoxia was analyzed using anti-Mab1 antibodies (in green). Note the
topographical relationship between HIF activation and pimonidazole
adduct formation. Bar: 50 m. C: Expression of HIF1 target genes
Pgk1, LdhA, Glut1, Vegf, and Redd1 was analyzed by qPCR in pancre-
ata cultured in collagen for 1 day at 21% ( ) or 80% (f)O 2. Gene
expression is presented as a percentage of the highest sample. Each
point represents the mean  SEM of three individual pools. *P < 0.05;
**P < 0.01. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
FIG. 4. DMOG, an inhibitor of prolyl hydroxylases, stabilizes HIF1
and represses -cell differentiation. A: Pancreata at E13.5 were cultured
at the air-medium interface for 1 day at 21 or 3% O2, and HIF1 was
analyzed by Western blot. B: Real-time PCR quantiﬁcation of Ngn3 mRNA
in pancreata cultured for 1 day at 21% (f)o r3 %( )O 2. Gene expression
is presented as a percentage of the highest sample. Each point represents
the mean  SEM of three individual pools. *P < 0.05. C: Pancreata were
cultured for 7 days at the air-medium interface at 21 or 3% O2. Immuno-
histochemistry was used to detect - and acinar cells using antibodies
directed against insulin (in red) and carboxypeptidase A (in green). Next,
the absolute surface occupied by insulin-positive cells was quantiﬁed.
Black and gray bars represent the surface of insulin-positive cells in
pancreata cultured at 21 and 3% O2, respectively. **P<0.01. D: Pancreata
at E13.5 were cultured at the air-medium interface for 1 day in the
presence or absence of 1 or 2 mmol/l DMOG, and HIF1 was analyzed by
Western blot. E: Real-time PCR quantiﬁcation of Ngn3 mRNA in pancre-
ata cultured for 1 day with 0 (f) ,1( ), or 2 () mmol/l DMOG at 21%
O2.* * P < 0.01. F: Pancreata cultured in the presence or absence of 1
mmol/l DMOG for 7 days were analyzed by immunohistochemistry. Acinar
cells were detected using anti–carboxypeptidase A antibody (in green)
and -cells using anti-insulin antibody (in red). Next, the absolute surface
occupied by insulin-positive cells was quantiﬁed. Gray and black bars
represent the surface of insulin-positive cells in pancreata cultured at
21% O2 with or without DMOG, respectively. ***P<0.001. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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4E) and protein (supplementary Fig. S8). We further
validated such results using L-mimosine, another inhibitor
of prolyl hydroxylases (29–31). L-mimosine treatment re-
sulted in HIF1 stabilization and repression of Ngn3
expression (supplementary Fig. S9). In addition, quantiﬁ-
cation of insulin staining indicated a sixfold decrease in
-cell development after 7 days of culture with DMOG
compared with a culture without DMOG (Fig. 4F). Taken
together, these results indicate that HIF1 represses Ngn3
expression and, consequently, negatively regulates -cell
differentiation.
Hypoxia regulates Hes1 expression via HIF1. Based
on our present discovery that collagen-cultured tissues are
hypoxic, we hypothesized that hypoxia could control the
expression of Hes1, a transcription factor involved in
pancreas development (25). To prove this, we cultured
E13.5 rat pancreata on ﬁlter with 3 and 21% O2 and
quantiﬁed expression of Hes1. We found that Hes1 expres-
sion is activated by hypoxia (Fig. 5A). Results were similar
when DMOG was added to pancreata cultured at normoxia
(Fig. 5B). To investigate whether hypoxia inhibits -cell
differentiation by regulating Hes1 expression, we cultured
pancreata under hypoxic conditions in the presence and
absence of a -secretase inhibitor that inhibits the cleav-
age of Notch. In several cell types, Hes1 has been de-
scribed as a target of the Notch-activated receptor (11,32),
but such a ﬁnding remains to be demonstrated in the
pancreas (33,34). We thus ﬁrst tested the effect of -secre-
tase inhibitor XXI (Calbiochem) on HES1. Cultures of
pancreatic explants were performed in the presence or ab-
sence of -secretase inhibitor, and HES1 protein expres-
sion was visualized using immunohistochemistry.
-Secretase inhibitor abolished HES1 protein expression
(supplementary Fig. S10). Interestingly, whereas in the
absence of the -secretase inhibitor hypoxia decreased
Ngn3 expression, the presence of the -secretase inhibitor
restored Ngn3 expression (Fig. 5C). To further compare
the effects of hypoxia and DMOG treatment, we cultured
pancreata with DMOG in the presence or absence of
-secretase inhibitor. As shown in Fig. 5C, -secretase
inhibitor also abolishes the repression of Ngn3 in DMOG-
treated explants. Thus, these results demonstrate that
both hypoxia and DMOG require expression of Hes1 to
repress Ngn3.
HIF1 protein expression decreases during pancreatic
development. Immunohistochemistry results showed that
at E11.5 and E12.5, HIF1 is present in both pancreatic
epithelium and mesenchyme (Fig. 6A). Interestingly,
HIF1 levels are reduced at E16.5. By E20.5, HIF1
expression decreased sharply and was rarely detected
(Fig. 6A) and pancreatic islet cells stained negative for
HIF1 (Fig. 6). Finally, HIF1 is absent in the adult
pancreas (Fig. 6A). Such a speciﬁc temporal pattern of
expression was conﬁrmed using Western blot analysis
(supplementary Fig. S11).
Hypoxia decreases -cell development in vivo. To
investigate whether pO2 regulates endocrine differentia-
tion in vivo, we exposed pregnant rats at 13.5 days
postcoitus to hypoxia at 8% O2 or normoxia at 21% O2
during 24 h as previously described (9). We next dissected
the embryonic pancreases at E14.5. Expression of NGN3
was examined using immunohistochemistry, and expres-
sion of the HIF1 target genes were quantiﬁed using qPCR.
We found that NGN3 expression was dramatically reduced
in hypoxia compared with that in normoxia while the
HIF1 target genes were induced (Fig. 6B). We thus
conclude that experimental hypoxia downregulates endo-
crine differentiation in vivo as well as in vitro.
DISCUSSION
Previously, we showed that in vitro, mature -cells de-
velop efﬁciently from rat embryonic pancreas grown at the
air-medium interface, whereas -cell development is poor
when the same tissue is grown in collagen (23,24). Our
working hypothesis was that hypoxia occurred in collagen
gel, activating the Notch pathway and inhibiting endocrine
differentiation (23,24,35). In our present study, we used
pimonidazole staining to demonstrate that pancreata cul-
tured in collagen were hypoxic compared with cultures
grown at the air-medium interface. We also found that in
vitro, the level of HIF1—a factor involved in regulation of
many hypoxic responses (36)—increased in the pancreas
as O2 tension decreased and that it repressed pancreatic
-cell differentiation. At the difference to HIF1, the factor
A
C
N
u
m
b
e
r
 
o
f
 
N
g
n
3
 
c
e
l
l
s
γ
-
s
e
c
r
e
t
a
s
e
 
i
n
h
i
b
i
t
o
r
R
e
l
a
t
i
v
e
 
H
e
s
1
 
m
R
N
A
R
e
l
a
t
i
v
e
 
H
e
s
1
 
m
R
N
A
21%
21% O2
21% O2
+
–
– –
+
21% O2 + DMOG
DMOG (1mM)
DMOG mM
3% O2
3% O2 21% O2
3% 0 1 2
800
400
600
200
0
** *
B
100
50
0
*
**
**
100
50
0
FIG. 5. Regulation of Hes1 expression by hypoxia. A: Real-time PCR
quantiﬁcation of Hes1 mRNA in pancreata cultured at the air-medium
interface with 21% (f)o r3 %( )O 2 for 1 day. *P < 0.05. B: Real-time
PCR quantiﬁcation of Hes1 mRNA in pancreata cultured at the air-
medium interface with 0 (f) ,1( ), or 2 (e) mmol/l DMOG for 1 day.
**P < 0.01. C: Detection of Ngn3 transcripts by in situ hybridization in
pancreata cultured for 1 day at 21% O2, 21%O2 with DMOG, or 3% O2
with or without -secretase inhibitor treatment. Epithelium is circled
in black in each panel. The absolute number of Ngn3-positive cells was
quantiﬁed in each condition in the presence (f) or absence (e)o f
-secretase inhibitor treatment. *P < 0.05; **P < 0.01. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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culture conditions (supplementary Fig. 3) or in VHL mu-
tant mice (37). Data from literature indicate that HIF2 is
expressed during embryonic development mainly in endo-
thelial cells (7,38,39). It is thus possible that variations of
HIF2 in the pancreatic endothelial cells may have inﬂu-
enced the development of endocrine cells in our experi-
ments (17). However, our results indicating that hypoxia
and DMOG do not stabilize HIF2 do not favor this
hypothesis.
Oxygen is known to control cell differentiation in differ-
ent tissues. For example, hypoxia blocks myogenic and
neuronal differentiation (11), and it arrests preadipocytes
in an undifferentiated state (12,40). Thus, hypoxia seems
to play a major role in maintaining a pool of undifferenti-
ated stem/progenitor cells—a process important for their
proper ampliﬁcation. The fact that oxygen tension is low
during early human and rodent development, when pro-
genitor cell expansion is taking place (41,42), further
supports this hypothesis. Recently, Fraker et al. (43)
proposed that pO2 plays a role in -cell differentiation
based on results with embryonic pancreata cultured on a
silicone-perﬂuorocarbone membrane at different O2 con-
centrations. However, the mechanism by which O2 medi-
ated its effects was not elucidated.
Recent data indicate that hypoxia, via HIF1, regulates
limb bud differentiation. In this tissue, Provot et al. (44)
proposed that condensation of the mesenchyme leads to
local hypoxia that stabilizes HIF1 levels. Pancreatic
anatomy during development suggests that pancreatic
endocrine cell development could be controlled in the
same way. Here we show that in vivo, HIF1 levels are
high at E11.5–E12.5 in the undifferentiated rat epithelium
and in the mesenchyme, indicating that the pancreas is
hypoxic at this early stage. This ﬁnding suggests that
hypoxia could maintain the pool of progenitor cells in
vivo. Moreover, when pregnant rats at 13.5 days postcoitus
were exposed to hypoxia for 24 h, the developing embry-
onic pancreata failed to express NGN3 (Fig. 6B). This
experimental ﬁnding supports the hypothesis that oxygen
is a limiting parameter for -cell differentiation in vivo.
Moreover, cultures of pancreata with different physiolog-
ical oxygen tensions showed that O2 is required for -cell
development in vitro (Fig. 4 and data not shown). In fact,
pO2 inﬂuences both the proliferation of the progenitor
cells (supplementary Fig. S6) and development of -cells
(Figs. 1 and 4). This ﬁnding should be considered when in
vitro models are used to characterize the molecular mech-
anisms that control the development of the pancreas.
Finally, we also found that increasing pO2 to nonphysi-
ological levels can enhance the development of -cells in
vitro (data not shown). This ﬁnding suggests that oxygen
could be used as a new tool to generate -cells in vitro.
Recent studies have described the pancreatic phenotype
of mice with different deletions of VHL or HIF1 (37,45–
47). Interestingly, Cantley et al. (37) used a pPDX1-cre
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FIG. 6. HIF1 protein expression during pancreatic development in vivo. A: Immunohistochemical analysis of HIF1 protein expression (in
brown) in pancreata at E11.5, E12.5, E16.5, E20.5, and adult phases. In the left panel, epithelium is circled in black. In the right panel,a
pancreatic islet is circled in black. Antibodies against PDX1 (in green) and insulin (INS) (in red) were used on serial sections to visualize
progenitors and -cells, respectively. B: NGN3 expression is repressed in the pancreas of embryos exposed to hypoxia. Pregnant rats were
maintained with 21 or 8% O2 for 24 h. Animal weight did not differ between the hypoxic and normoxic groups. The pancreata were harvested at
E14.5 and analyzed by immunohistochemistry and qPCR. Detection of NGN3 (brown; **P < 0.01). Expression of HIF1 target genes, Pgk1, LdhA,
Glut-1, Vegf-A, and Redd1 in pancreata in hypoxia (e) or normoxia (f). *P < 0.05; ***P < 0.001. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
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life. They found that 12 weeks after birth, HIF1 was
increased but -cell mass was not modiﬁed. The differ-
ence between these results and ours could be due to the
fact that -cell mass was analyzed 12 weeks after birth,
while VHL deletion had not occurred in all targeted cells
(37). It is thus possible that compensation occurred
during this developmental period. Moreover, Cantley et
al. (37) used Pdx1-CRE recombinase to delete VHL in
pancreatic progenitors. However, we found that at E11.5
and E12.5, HIF1 was expressed in PDX1-positive pan-
creatic progenitor cells but also in surrounding mesen-
chymal cells. This observation was found both in vivo
and in vitro (Fig. 3B; supplementary Figs. 5A and 6). We
thus cannot exclude the possibility that HIF1,i n
addition to its role in progenitor cells, modiﬁes epithe-
lio-mesenchymal interactions that are known to be of
major importance for pancreas development (24,48,49).
One possibility could be that hypoxia modiﬁes the
signals from the mesenchyme, e.g., the ones mediated
by FGF10 or Delta-like 1. Neither FGF10 nor delta-like 1
mRNA steady-state levels signiﬁcantly differ in the ex-
plants cultured in hypoxia compared with those in
normoxia (data not shown). Further genetic studies
using conditional knockout of HIF1 in mice or siRNA
in cultured pancreatic explants will be necessary to
analyze whether the effects of hypoxia on the epithelium
are direct or involve the pancreatic mesenchyme.
In the present study, we demonstrate that the level of
expression of Ngn3, which is a basic helix-loop-helix
transcription factor expressed in islet cell progenitors and
which is necessary to initiate the endocrine differentiation
program (21,50), was inversely related to HIF1 levels.
Interestingly, Ngn3 expression and pancreatic endocrine
cell development are tightly regulated by Hes1. For exam-
ple, deletion of Hes1, which is thought to be a target of the
activated cleaved Notch, led to precocious endocrine cell
differentiation, depletion of the progenitor cell pool, and a
decrease in pancreatic cell mass (25). In the present study,
we used a -secretase inhibitor to block the Notch path-
way. While -secretase inhibitors have been used with
success for this purpose (11,51,52), other substrates of the
-secretase inhibitor have been listed, such as ErbB1
(epidermal growth factor receptor [EGFR]) and ErbB4,
that are also involved in pancreas development (53–55)
and we thus cannot exclude that -secretase inhibitor also
acts on other pathways. Recent data indicate that -secre-
tase inhibitor is able to repress HES1 expression within
pancreatic explants (56). Our data conﬁrmed this effect
(supplementary Fig. S10). Importantly, in the presence of
-secretase inhibitor, the effects of hypoxia and DMOG on
Ngn3 expression were alleviated. We thus concluded that
HES1 was necessary for these effects, but the exact role of
the Notch receptor should be clariﬁed in further studies.
Moreover, our data indicate that hypoxia activates Hes1
through HIF1. Recently, a direct link was found between
hypoxia and Notch signaling, and it is now proposed that
these two pathways interact to inhibit differentiation of
myogenic and neuronal progenitors during early stages of
embryogenesis (11,57). Gustafsson et al. (11) reported that
pharmacological inhibition of Notch signaling by a -secre-
tase inhibitor alleviates inhibition of differentiation under
hypoxic conditions. In addition, they reported a direct
physical interaction between HIF1 and the intracellular
domain of the activated Notch receptor; HIF1 was re-
cruited to Notch-responsive promoters upon Notch acti-
vation under hypoxic conditions (11). These data are
consistent with our ﬁndings and suggest that the mecha-
nism by which HIF1 activates the expression of Hes1
under hypoxic conditions also applies to pancreatic endo-
crine cell development. The HIF1-Hes1 pathway is thus a
good candidate for an explanation of the effects of
hypoxia.
Based on our observations, we speculate that hypoxia
induces HIF1 in early pancreatic progenitor cells, delay-
ing their differentiation into endocrine cells and thus
preserving a sufﬁcient pool of precursors necessary for
attaining an adequate ﬁnal -cell mass. These ﬁndings will
help shed light on the molecular mechanisms responsible
for -cell differentiation. In addition, they should help
deﬁne new protocols for deriving insulin-producing cells,
thereby improving options for cell replacement therapy in
type 1 diabetes.
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